Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Canada
  4. CANADIAN NATIONAL STOCK EXCHANGE
  5. Mindset Pharma Inc.
  6. News
  7. Summary
    MSET   CA60268M1023

MINDSET PHARMA INC.

(MSET)
SummaryQuotesChartsNewsCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Mindset Pharma : Further Validates Lead Candidate as Next Generation Psilocybin Analog Through Drug Discrimination Assay

09/14/2021 | 10:07am EDT


© MT Newswires 2021
All news about MINDSET PHARMA INC.
10/14MINDSET PHARMA : Expands Benchmarking Data for First Generation Psychedelics Through the C..
AQ
10/14Mindset Pharma Expands Benchmarking Data for First Generation Psychedelics Through the ..
CI
10/11KCSA Psychedelics Virtual Investor Conference Agenda Announced for October 13th & 14th
AQ
09/29MINDSET PHARMA EXPANDS PIPELINE : Identifies Additional Next Generation 5-MeO-DMT-Inspired..
GL
09/29Mindset Pharma Expands Pipeline Identifies Additional Next Generation 5-MeO-DMT-Inspire..
CI
09/23Mindset Pharma Announces Inclusion in NYSE Listed AdvisorShares Psychedelics Exchange T..
GL
09/20Mindset Pharma Announces Further Preclinical Results Demonstrating Strong Efficacy and ..
GL
09/20Mindset Pharma Inc. Announces Further Preclinical Results Demonstrating Strong Efficacy..
CI
09/14MINDSET PHARMA : Further Validates Lead Candidate as Next Generation Psilocybin Analog Thr..
MT
09/14MINDSET PHARMA : Further Validates Lead Candidate, MSP-1014, as a Next Generation Psilocyb..
AQ
More news
Financials
Sales 2020 - - -
Net income 2020 -0,64 M -0,52 M -0,52 M
Net cash 2020 0,54 M 0,44 M 0,44 M
P/E ratio 2020 -
Yield 2020 -
Capitalization 67,6 M 54,7 M 54,6 M
EV / Sales 2019
EV / Sales 2020 -
Nbr of Employees -
Free-Float -
Chart MINDSET PHARMA INC.
Duration : Period :
Mindset Pharma Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
James Andre Charles Lanthier Chief Executive Officer
Arvin Ramos Chief Financial Officer
Richard J. Patricio Chairman
Joseph Araujo Director & Chief Science Officer
James Christopher Passin Director
Sector and Competitors
1st jan.Capi. (M$)
MINDSET PHARMA INC.-18.09%55
MODERNA, INC.210.34%130 866
LONZA GROUP AG26.90%58 060
IQVIA HOLDINGS INC.38.89%47 683
SEAGEN INC.-1.38%31 426
CELLTRION, INC.-38.72%25 414